After a year of progress, scientists say they are on the cusp of turning AI-designed antibodies into potential therapies. In ...

A Cornell-led collaboration has devised a potentially low-cost method for producing antibodies for therapeutic treatments. They've bioengineered bacteria with an overlooked enzyme that can attach ...

When Mark Cuban talks about how his Cost Plus Drugs company can reduce prescription costs, his message is simple.

The U.S. Food and Drug Administration on Tuesday issued new draft guidance on reducing the use of lab monkeys in preclinical ...

The custom antibody market is projected to grow at a CAGR of roughly 10% over the forecast period. This expansion is fueled ...

According to research by SNS Insider, the U.S. Antibody Discovery Market is projected to grow at a CAGR of 8.13%, fueled by expanding biologics pipelines, strategic collaborations, and increased ...

A research team that includes Andrew Zydney, Bayard D. Kunkle Chair and professor of chemical engineering at Penn State, and ...

ADCs integrate monoclonal antibodies with cytotoxic payloads, offering new treatment options for NSCLC, including biomarker-selected and biomarker-agnostic patients. ADCs are composed of an antibody, ...